Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Preferred Stock Liabilities: 2020

Historic Preferred Stock Liabilities for Immuneering (IMRX) over the last 1 years, with Dec 2020 value amounting to $58.1 million.

  • Immuneering's Preferred Stock Liabilities was N/A to $82.9 million in Q2 2021 from the same period last year, while for Jun 2021 it was $82.9 million, marking a year-over-year change of. This contributed to the annual value of $58.1 million for FY2020, which is N/A change from last year.
  • Per Immuneering's latest filing, its Preferred Stock Liabilities stood at $58.1 million for FY2020.
  • Immuneering's 5-year Preferred Stock Liabilities high stood at $58.1 million for FY2020, and its period low was $58.1 million during FY2020.
  • Over the past 1 years, Immuneering's median Preferred Stock Liabilities value was $58.1 million (recorded in 2020), while the average stood at $58.1 million.